Introduction
Basal cell carcinoma (BCC) is a slow-growing, locally invasive malignant skin tumor with a highly irregular infiltration pattern. Whilst rarely life-threatening, the high incidence and local invasiveness of BCC make it a major public health concern [1, 2] . The malignant extensions of BCC are often not clinically detectable due to the microscopic nature of the tumor spread [3] . In standard surgical excision (SSE), therefore, a predetermined margin (typically 3-5 mm) ensures that, in most cases, all sub-clinical spread will be excised [4] . Where there is a high risk of recurrence, particularly in large lesions, those with poorly defined borders, and those occurring on the face, Mohs micrographic surgery (MMS) is preferred [5, 6] . In MMS, staged excisions are controlled intraoperatively by histological analysis, providing a low recurrence rate (52%) and optimum sparing of healthy tissue, although at a greater cost than SSE [5] .
Non-invasive imaging technologies offer the potential for more accurate assessment of the pre-surgical border of a BCC by revealing sub-clinical spread. Dermoscopy, for example, is an established clinical aid [7] that offers some improvement in defining a preoperative border in SSE that otherwise relies wholly on effective visual assessment [8] . However, pre-surgical assessment with dermoscopy has not been shown to lead to any reduction in the total number of MMS stages required for complete excision [9] . Similarly, high-resolution ultrasound generally provides insufficient contrast in subtle areas of tumor extension to be of significant clinical value in preoperative mapping of BCC [10, 11] .
The emerging high-resolution, non-invasive optical imaging technologies, including reflectance confocal microscopy (RCM) and optical coherence tomography (OCT) [12, 13] , offer increased potential for identifying sub-clinical spread of BCC [14] . Clinical RCM, for example, has demonstrated promise in mapping cellular-level features of residual BCC in shave biopsy wounds [15] and in a small clinical study of preoperative BCC margin mapping [16] . However, RCM can image only as deep as the superficial dermis and requires skin contact and a coupling fluid, making it difficult to image surfaces that are not flat. By contrast, OCT, a cheaper technology, can provide contact-free imaging to a depth of approximately 1.5 mm in skin and has been widely shown to provide reasonable correspondence with histological features of BCC [17] [18] [19] [20] . An initial attempt to map a BCC border in the clinic using OCT has been presented as a single case study [21] . This showed qualitative agreement between the OCT-imaged lateral margins of a single BCC and the corresponding histologically confirmed margins.
The study presented here examines the extent of BCC infiltration across the pre-surgical clinical border using OCT. The OCT-defined border is compared with the final MMS defect. Dermoscopy has been employed to record the position of the clinical border of the BCC. A novel software algorithm, based on an interpolating thin-plate spline transformation [22] , has been developed to register this border with the corresponding 3D OCT image data. Automated registration of OCT and dermoscopy offers the advantages of speed and accuracy over the manual registration of surface features as used by Pomerantz et al. [21] .
Methods

Imaging and registration
Optical coherence tomography was performed using a commercial system, the VivoSight 1500 OCT system [23] (Michelson Diagnostics Ltd., Orpington, UK). With this system, the lateral and axial optical resolutions achieved in tissue are nominally 7.5 mm and 10 mm, respectively. The VivoSight hand-held probe was fitted for this study with a miniature webcam by the manufacturer (Figure 1a) . The webcam is rigidly mounted in the rim of the scanning head with its viewing axis lying at an angle (24 ) to the OCT beam axis. It both serves as an aid in locating the OCT probe over a lesion under visual guidance and provides an image of a fiducial marker on the skin to aid registration of the OCT and dermoscopy images. Digital dermoscopy was performed using the Heine Delta 20 dermoscopic attachment (Heine Optotechnik, Herrsching, Germany) fitted to a Nikon DS300 digital camera (Figure 1b) .
For this study, 3D OCT datasets were obtained at 6 fps, in the form of a stack of 250 ''B-scan'' OCT images of 1,338-pixel width, spaced at 20 mm and covering a 5 mm Â 5 mm area of skin to a depth of 1.5 mm in a single 40-second scan. Registration of this 3D dataset with a dermoscopic image of the skin surface was carried out off-line using a software algorithm described in the Appendix to this paper. Briefly, the algorithm involves first rectifying the webcam image to correct for the 24 offset from the OCT beam axis. The rectified image provides a view of the skin as if the webcam had been directed along the OCT beam axis. The digital dermoscopic image of the lesion is then rotated, translated and stretched so that the image of the fiducial marker coincides with that from the rectified webcam image. The result is a dermoscopic image registered with the 3D OCT dataset. A 3D skin surface is then obtained from the OCT dataset by suitable thresholding, and the registered dermoscopic image is fused onto the 3D surface of the OCT dataset. The resulting combined OCT-dermoscopy dataset is rendered in 3D in an open-source software package (Paraview Õ ).
Clinical study
A preliminary clinical evaluation of the dual OCTdermoscopy imaging system was carried out by comparing the OCT-assessed and visual pre-surgical borders. These borders were then compared with the final MMS defect. Seventeen patients, 7 females and 10 males with a mean age of 67 years (range: 46-86 years), were recruited opportunistically from any willing adults (418 years old) with histologically confirmed BCC attending Guy's & St. Thomas' NHS Hospital Foundation Trust for MMS. Patients were excluded only if the skin at and around the BCC was broken. The surgeon marked the pre-surgical clinical border of the BCC in ink on the patient's skin. A circular fiducial marker was then located at a position straddling an arbitrarily selected segment of this Figure 1 . (a) The hand-held OCT probe from the VivoSight 1500 OCT system fitted for this study with a miniature webcam (arrowed), and (b) the Heine Delta 20 dermoscopic attachment to the Nikon DS300 digital camera.
pre-surgical border. The skin and the associated marker were then imaged by placing the hand-held OCT probe and dermatoscope in turn at the site of the border. The pre-surgical OCT and dermoscopy images were then registered and fused (see Appendix). A dermatologist inspected the 2D OCT images selected from the 3D rendered image in a plane that allowed measurement of the extent of any infiltration of BCC beyond the clinical border. After surgery, a clinical image was then obtained to record the extent of the surgical defect. The clinical image of the defect and the dermoscopic image of the lesion were registered by suitable rotation and magnification to match common surface features. Figure 2c ). The algorithm, described in the Appendix, is used to register and fuse the OCT dataset and dermoscopy image.
Results
Comparison of tumor borders
Surgical margins in MMS are typically $2 mm: A useful level of accuracy for delineating tumor borders is assumed, therefore, to be ±0.5 mm. Errors from the rectification of the webcam image are negligibly small (550 mm) because these systems are rigidly fixed to each other. The main source of errors affecting registration arises from the transformation of the dermoscopy and webcam images. This error can be assessed directly from comparison of the transformed and overlaid clinical images of the fiducial marker from the webcam and dermatoscope. Nine of the 17 cases had a maximum registration error of less than ±0.5 mm. The 8 cases with larger errors were excluded from the analysis presented here. The 9 retained cases (Table I) were assessed to have an average maximum registration error of ±0.25 mm (range: 0.12-0.49 mm). Registration of the clinical image of the final MMS with the OCT border was assessed to have an error of $1.0 mm The 9 cases summarized in Table I are classified according to BCC subtype. The number of MMS stages required to complete the resection is given in the third column. The final three columns of Table I give the mean values (in mm) for the distance between (i) the clinically assessed and OCT-assessed pre-surgical borders, (ii) the clinically assessed border and the border of the final surgical defect, and (iii) the OCT-assessed border and the final surgical defect border.
The first of the final three columns in Table I represents the degree of OCT-identified infiltration across a segment of the clinical border. The 4 symbol (patients 5-7) is used to indicate that, in these cases, the BCC extended beyond both the clinically assessed border and the FOV of the OCT system. BCC infiltration across the clinically assessed border of the BCC was noted in all cases except patients 3 and 4. Table I In patient 3, there was no disease noted either side of the clinical border, so no OCT border could be defined within the FOV of the scanner, while in patient 4 the clinical and OCT borders were coincident.
The extent of the surgical defect beyond the pre-surgical clinical border following MMS is given in the penultimate column of Table I . In patient 5, for example, there was a particularly large difference (17.8 mm) between the presurgical border and the final MMS defect. In this case the OCT system identified infiltration at least 2.5 mm beyond the clinical border, although the extent of infiltration could not be fully assessed because of the limited FOV. In the remaining cases, MMS resulted in resection of 2-4 mm of tissue beyond the clinical border of the lesion.
The difference between the final MMS defect and the OCTdefined pre-surgical border is given in the final column of Table I . These values, where available, are all less than 2 mm, with the OCT border remaining within the defect. Since the MMS defect includes a 2-mm margin of normal tissue, these results indicate that using the OCT-defined border with a 2-mm margin added would have resulted in a clear margin, at least at the segments analyzed, in all five cases. Indeed, four cases (patients 1, 2, 4 and 8) would have had at least one less MMS stage than they actually received. In cases 5, 6 and 7 at least one MMS stage may have been avoided.
Five cases (patients 1-5 in Table I ) are discussed in more detail in the following sections. These cases provide practical examples of the registration process, and also illustrate the variation in the OCT appearance of the lesion border in different BCC subtypes.
Nodular infiltrative BCC (Case 1)
A surface view of the 3D rendered image of the registered and fused OCT-dermoscopy dataset for the mixed nodular infiltrative BCC from patient 1 is shown in Figure 3(a) . This corresponds to the same lesion shown in Figure 2 . Using this 3D rendered image, the dermatologist can evaluate sub-clinical spread of BCC by selecting a suitable plane (shown in black in Figure 3a) to extract an OCT image that straddles the clinical border of the BCC. The ink marks delineating the clinical border can be seen in Figure 3 (a), which also shows some edema. The OCT image from the selected plane is shown in Figure 3 (Figure 4c) shows the raised lesion, the inked pre-surgical margin, and a selected plane through the pre-surgical margin (in black). The OCT image from the selected plane (Figure 4e) shows the surface contour of the skin and regions (arrowed) that are identified as BCC cell nests to the right and left of the clinical presurgical margin. The pre-surgical margin (long-dashed line), the OCT-defined margin (short-dashed line) and the final surgical defect (solid line) are shown in Figure 4(d) . The presurgical border is drawn simply to follow the ink marks on the skin.
In this case, infiltration is clearly identified from the OCT image beyond the clinical margin. The final surgical defect lies 2.3 mm from the clinical border and $1.4 mm from the OCT-defined border. Again, the degree of sub-clinical spread is small and would have been included within a standard 2-mm MMS margin at this segment of the border. Another nodular BCC, this time on the temple of patient 3, is shown in Figure 5 . The clinical images reveal an ulcerated nodular plaque ( Figure 5a ) and a surgical defect (Figure 5b ) that is somewhat larger than the pre-surgical clinical border. The OCT image (Figure 5e ) of the selected plane, illustrated in the 3D rendered image (Figure 5c ), shows few clinical features other than the presence of a particularly thin epidermis (arrowed) that is present across the entire FOV. The thinness of the epidermis, whilst a feature of superficial BCCs, is more likely related in this case to the location of this lesion on the temple. Hairs can be identified in the image as white dots above the skin surface that cast vertical line artefacts extending down from the dots into the OCT-imaged tissue, degrading parts of the image. It is not possible, from this image, to confirm the presence of sub-clinical spread of BCC or even to confirm the presence of BCC within the clinical border. Similarly, no information concerning the true extent of BCC infiltration can be inferred from the extent of the final MMS defect since this lies 2.3 mm beyond the clinical border, which simply represents the first MMS stage including a margin. It seems likely, in this case, that the clinical border was placed well beyond the true BCC border and the OCT scan therefore included only normal tissue.
Micronodular BCC (Case 4)
A case of micronodular BCC located on the nose of patient 4 is shown in Figure 6 . The clinical image (Figure 6a) shows two inked regions containing a slightly raised pale area within two inked margins. The inner margin is the clinical border of the lesion and the outer inked ring simply represents the 2-mm margin of healthy tissue included in the first MMS stage. The final surgical defect is seen in Figure 6 (b). In this case, the selected OCT image, straddling the pre-surgical margin (Figure 6c ), has a relatively homogeneous region with no sign of the dermal-epidermal junction (DEJ) to the left of the clinical border. Disruption of the DEJ is a characteristic feature seen in OCT images of BCC. To the right of the pre-surgical margin the normal appearance of the epidermal junction is seen (arrowed). The clinical and OCT borders are thus taken to be coincident in this segment of the lesion. The final MMS defect lies 3.5 mm beyond the clinical border, but follows closely the inked margin for the first stage. In this case, therefore, OCT has simply confirmed that there is no sub-clinical spread beyond the clinical border.
Micronodular BCC (Case 5)
The final example is another micronodular BCC, in this case on the forehead of patient 5 ( Figure 7 ). Two separate inked regions containing flat, pale tissue are shown in the clinical image (Figure 7a ). The final surgical defect (Figure 7b ) is, clearly, considerably larger than the visible lesion, which is illustrated for comparison in the form of a superimposed dotted line. This BCC, therefore, shows extensive sub-clinical spread that required more than three MMS stages for treatment. A selected OCT image that straddles the pre-surgical border (Figure 7c ) shows irregularly sized ovoid regions with bright borders, as well as large irregular dark regions (arrowed). These features extend both to the left and right of the clinical border (vertical line in Figure 7c ). It is concluded from the OCT imaging of this lesion that features characteristic of BCC cell nests extend to the limit of the FOV of the OCT system. No OCT lesion border can be defined in this case, and the OCT extent of this lesion is therefore represented as 42.5 mm. In this case, OCT has shown that there is sub-clinical spread throughout its FOV.
Only by scanning the probe could the OCT border have been delineated in this case.
Discussion
This clinical study demonstrates the value of automated registration of OCT and dermoscopy images of the same lesion. The system allowed identification of sub-clinical spread of BCC across the visually assessed pre-surgical margin of BCCs with an accuracy of around 0.5 mm.
The key finding of the study is that OCT can be used to assess the degree of sub-clinical spread prior to MMS. Such spread of BCC was identified in 7 of the 9 analyzed cases. In one case, the clinical and OCT borders were coincident and in another no OCT border could be seen. The degree of infiltration, in the cases where it could be assessed within the FOV limitations, was less than $2.0 mm in all but one case. In these cases, OCT would have added relatively little clinical value, since a 2.0-mm surgical margin would have included any infiltration in the first MMS stage. However, in at least one case, there was a large discrepancy between the clinical border and the final surgical defect. The use of OCT would have raised concern over the accuracy of the clinical border in this case, and would have led to a reassessment of this border with a consequent reduction in the number of MMS stages.
Visual registration was used to compare the OCT border of the BCC with the final MMS defect. It is interesting to note that there were no instances where the OCT-assessed border exceeded the final MMS defect. Indeed, in those cases that could be assessed, the OCT border was within $2 mm of the final MMS defect. The clinical borders, by contrast, ranged between approximately 2 mm and 18 mm from the defect. Such a result, if repeated in a larger clinical study without the FOV limitations, would suggest a valuable role for OCT in assessing a more accurate pre-surgical border with the aim of limiting the number of MMS stages.
Most of the cases included in this study showed only a small amount of sub-clinical spread in the segment analyzed by OCT. If this degree of spread was seen around the entire border, then these lesions could have simply been treated by SSE with a 3-mm margin. Case 5, however, with extensive spread, was clearly only suitable for MMS, since the likelihood of incomplete resection and recurrence was high. Large lesions and those with more poorly defined margins have a higher risk of recurrence. It seems feasible that OCT, as well as offering the potential to map preoperative margins, may have a role as a screening tool to assist in selecting the type of surgical treatment: either SSE or MMS.
The present study was limited by the relatively small number of cases analyzed and by the fact that the OCT probe was static, rather than being scanned manually under the dermatologist's control. The small size of the study is partly the result of the long scan time used (40 s), which resulted in the exclusion from the analysis of just under half of the recruited patients due to poor registration accuracy resulting from excessive movement. The study was also limited by the relatively small FOV of the OCT system, which, because of time constraints, made it feasible for only one segment of the border to be rapidly imaged in the clinical setting. However, neither the FOV limitation nor the scan time represent insurmountable technical obstacles to OCT border delineation. Finke et al. [24] , for example, have achieved a larger FOV (16 Â 12.5 mm) by scanning the OCT beam in a system designed for intraoperative imaging. A more immediately practical option would be to scan a larger region manually in real time using rapid 2D rather than slow 3D OCT imaging.
A more fundamental limitation of OCT in mapping the tumor border may be the inherently low contrast of clinical features in OCT images. Nodular BCC is typically well characterized in OCT images, with the border of the cell nests having a relatively high contrast. However, the clinical features of nodular BCC on the skin surface are also quite distinct, with pearly white, dome-shaped papules having prominent telangiectatic surface vessels and, frequently, an elevated shiny border. As a result, OCT may not add much to the visual assessment of the border in these cases. The greatest value is likely to be in cases where the BCC infiltrates widely and deeply, with relatively little change in the overlying skin surface appearance. This is common in the more aggressive BCC subtypes, including ''infiltrative'' and ''micronodular'' BCCs, which constitute approximately 20% of all BCCs and which are most appropriately treated by MMS. These lesions can appear as flat, ill-defined areas of skin where the texture and color changes can be subtle, making the clinical border difficult to define. Whilst subtypes can be identified on OCT [25] , it remains to be demonstrated whether the lesion borders can always be easily delineated on OCT and to what extent OCT adds value if borders are not precisely delineated.
Improved visualization of BCCs may be obtained using ''high-definition'' OCT systems. A recent study has shown that these are capable of providing more detailed features of infiltrative and other BCC subtypes [26] . The same study also confirmed that the OCT borders of the more aggressive subtypes are less well defined. Although such OCT systems offer approximately three times the axial and lateral resolution (3 mm) of the VivoSight system used here, they provide only a third of the penetration ($0.5 mm) and a reduced FOV (1.8 Â 1.5 mm). It remains to be seen which specification of system proves the most valuable in mapping borders of the range of BCC subtypes.
Conclusion
This study demonstrates the value of using an adapted OCT system with automated OCT-dermoscopy image registration. The system was able to measure with adequate accuracy (50.5 mm) the degree of sub-clinical spread of BCC. The results of this preliminary clinical study support the conclusion that OCT may have the potential to influence the selection of patients for MMS, and may be able to influence the duration of MMS by reducing the number of surgical stages. The study was limited by the constraints involved in seeking highly accurate automated registration. This limited the scope to examining the entire border of the BCC or scanning the OCT probe free-hand across the lesion. An OCT probe that can be manually scanned whilst also providing registration is being developed as the next phase of this work. 
Appendix: Image registration and fusion
Coordinate transformations
The webcam is rigidly fixed to the OCT probe such that the angle between the beam axes of the two imaging systems is constant (Figure 1a) . A calibration is performed to relate the 2D webcam (u, v) T and 3D OCT (x, y, z) T coordinate systems. This calibration provides the components of a 3 Â 4 calibration matrix P W , where P W is defined by
where is a scaling factor. [27] is used to find an initial estimate for P W . This estimate is then decomposed and the parameters used as input into an iterative algorithm. In practice, the mean residual calibration error was 0.64 pixels. A second calibration is performed to obtain a coordinate transformation, P D , linking the dermoscope and OCT coordinate systems. A similar equation to that shown above (Equation 1) describes this transformation. In this case, the test object consisted of grid lines etched on opposite surfaces of a 1-mm-thick Perspex sheet. The dermatoscope is placed in contact with the top surface of the Perspex and an image of the two grids as seen from this surface is acquired. The upper and lower grid line intersection points can be separately identified in this image. With the dermoscope removed, the test object is then located in a plane orthogonal to the beam axis of the OCT probe and a 3D OCT image stack acquired as before. The OCT image stack can be used to obtain pinhole coordinates at the grid line intersections on both surfaces of the Perspex test object. Again, a direct linear transformation algorithm [27] is used to find an initial estimate for P D . This estimate is then decomposed and the parameters used as input into an iterative algorithm. In practice, the mean residual calibration error was 0.3 pixels.
Any translational and rotational components of P D are specific to the particular calibration set-up and will not apply generally. In the clinic, therefore, a fiducial marker is placed close to the lesion to provide the information necessary to extract the translational and rotational transformations required to register the images. This process is described in the next section. The calibration matrix obtained from calibration alone is, therefore, valid only for an arbitrary dermoscopy image position subject to an additional translation and rotation.
Image registration
A diagram of the main steps in the rectification and fusion algorithm is provided in Figure 8 . A webcam image of the fiducial marker (Figure 8a ) is first transformed into the dermoscopy coordinate system (D) -a process known as rectification. Rectification is achieved by casting a ray, using P D , from each pixel in D. The intersection of this ray with the particular plane containing the image of the fiducial marker in the OCT space is then found. A ray projected from this intersection point, using P W, is then cast so that it intersects the webcam image space (W). The pixel intensity at this position in W is then acquired and transferred to the corresponding pixel in D to generate a rectified webcam image of the fiducial marker. The result is that both the dermoscopic (Figure 8b ) and rectified webcam images of the fiducial marker lie in the same plane but are not necessarily registered. An interpolating thin-plate spline transformation [19] is used to non-rigidly register these two separate images, using landmarks picked on the fiducial marker. The OCT scans ( Figure 8c ) were segmented into two regions using intensity-based threshold. A rolling window was preferred to a simple intensity threshold as this allowed some smaller artefacts above the skin surface to be ignored. An active contour segmentation was then applied to the segmented dataset using ITK-Snap [28] to create a surface mesh. The images are smoothed, triangulated and decimated. The registered dermoscopy image was then overlaid onto this surface by projecting, using P D , each point from the mesh into the registered dermoscopy image and assigning the corresponding RGB intensity values to the mesh point. The overlaid mesh and the OCT scan were 3D rendered in Paraview Õ (Figure 8d ).
